TITLE

ORIGINAL ARTICLE IgA Autoimmune Disorders: Development of a Passive Transfer Mouse Model

AUTHOR(S)
Zone, John J.; Egan, C. Anthony; Taylor, Ted B.; Meyer, Laurence J.
PUB. DATE
January 2004
SOURCE
Journal of Investigative Dermatology Symposium Proceedings;Jan2004, Vol. 9 Issue 1, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
IgA is present in the skin in several dermatoses, including dermatitis herpetiformis, linear IgA bullous dermatosis, and Henoch-Schoenlein purpura. The neutrophilic infiltration in the area of the IgA deposition suggests that IgA is responsible for the associated inflammatory events. The mechanism for this process is unproven, but is likely to involve IgA-mediated neutrophil chemotaxis with inhibition of chemotaxis by dapsone. Elucidation of the mechanism of IgA-mediated inflammation will require an animal model. We have established a model for linear IgA bullous dermatosis as a prototype disease to be studied. IgA mouse monoclonal antibodies against a linear IgA bullous dermatosis antigen have been passively transferred to SCID mice with human skin grafts. This has produced neutrophil infiltration and basement membrane vesiculation in 4 of 12 mice tested. We conclude that an animal model for the pathogenesis of IgA dermatoses with IgA deposition and inflammation can be produced by passive transfer of mouse IgA antibodies against a linear IgA antigen.
ACCESSION #
11862060

 

Related Articles

  • In This Issue... Emanuel, Janet Rettig // Journal of Investigative Dermatology;Apr93, Vol. 100 Issue 4, p347 

    Dapsone provides effective therapy for skin diseases in which there is deposition of immunoglobulin (Ig) accompanied by an accumulation of neutrophils. Although dapsone disrupts several metabolic functions in neutrophils, it also inhibits accumulation of these cells in the skin. Neutrophils...

  • Inhibition of Neutrophil Adherence to Antibody by Daspone: A Possible Therapeutic Mechanism of Dapsone in the Treatment of IgA Dermatoses. Thuong-Nguyen, Vu; Kadunce, Donald P.; Hendrix, John D.; Gammon, W. Ray; Zone, John J. // Journal of Investigative Dermatology;Apr93, Vol. 100 Issue 4, p349 

    Dapsone is frequently effective in cutaneous diseases characterized by antibody deposition and accumulation of neutrophils. We hypothesized that this mechanism of action of dapsone may involve the inhibition of neutrophil adherence to antibody. the neutrophil adherence assay, which measures the...

  • Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742. Z. Haskova; B. Hoang; G. Luo; L. Morgan; A. Billin; B. Shearer; M. Barton; K. Kilgore // Inflammation Research;Jul2008, Vol. 57 Issue 7, p314 

    Abstract. Objective:  To define the anti-inflammatory effects of PPARβ/δ activation by use of the selective PPARβ/δ ligand (GW0742) in a model of lipopolysaccharide (LPS)-induced pulmonary inflammation. Methods:  Male BALB/c mice...

  • Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid. Vafia, Katerina; Groth, Stephanie; Beckmann, Tina; Hirose, Misa; Dworschak, Jenny; Recke, Andreas; Ludwig, Ralf J.; Hashimoto, Takashi; Zillikens, Detlef; Schmidt, Enno // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Recently, the C-terminus of laminin γ1 has been identified as target antigen in anti-p200 pemphigoid and the disease was renamed as anti-laminin γ1 pemphigoid. However, the pathogenic relevance of these autoantibodies has not yet been demonstrated. Therefore, we employed an ex vivo model...

  • Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System. Little, Mark A.; Al-Ani, Bahjat; Ren, Shuyu; Al-Nuaimi, Hamad; Leite Jr., Maurilo; Alpers, Charles E.; Savage, Caroline O.; Duffield, Jeremy S. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Evidence is lacking for direct pathogenicity of human anti-proteinase-3 (PR3) antibodies in development of systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener's granulomatosis). Progress in study of these antibodies in rodents has been hampered by lack of PR3 expression on...

  • Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin. Kato, Kiyonari; Kosugi, Tomoki; Sato, Waichi; Arata-Kawai, Hanayo; Ozaki, Takenori; Tsuboi, Naotake; Ito, Isao; Tawada, Hideo; Yuzawa, Yukio; Matsuo, Seiichi; Kadomatsu, Kenji; Maruyama, Shoichi // Clinical & Experimental Nephrology;Jun2011, Vol. 15 Issue 3, p346 

    Background: Growth factor Midkine (MK), which expresses on endothelial cells and renal proximal tubules, has been implicated in inflammation-related kidney diseases such as ischemic reperfusion-induced tubulointerstitial injury and diabetic nephropathy. The biological actions of MK are elicited...

  • Modulation of Inflammatory Processes by Leaves Extract from Clusia nemorosa Both In Vitro and In Vivo Animal Models. Farias, José; Ferro, Jamylle; Silva, Juliane; Agra, Isabela; Oliveira, Fernando; Candea, André; Conte, Fernando; Ferraris, Fausto; Henriques, Maria das Graças; Conserva, Lucia; Barreto, Emiliano // Inflammation;Apr2012, Vol. 35 Issue 2, p764 

    The present study was carried out to investigate the anti-inflammatory effect of the hexane extract of the leaves from Clusia nemorosa G. Mey, called HECn, using carrageenan-induced mice pleurisy and cotton pellet-induced mice granuloma. Additionally, the ability of HECn to affect both...

  • A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu Mice. Fairley, Janet A.; Burnett, Christopher T.; Chang-Ling Fu; Larson, David L.; Fleming, Matthew G.; Giudice, George J. // Journal of Investigative Dermatology;Nov2007, Vol. 127 Issue 11, p2605 

    Bullous pemphigoid (BP) is an autoimmune disease characterized by subepidermal blistering. Based on previous work, IgG autoantibodies directed against BP180 are thought to be the primary pathogenic agent in BP. In addition to these IgG autoantibodies, however, most BP patients produce IgE class...

  • Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus. Racz, Z.; Nagy, E.; Rosivall, L.; Szebeni, J.; Hamar, P. // Lupus;Apr2010, Vol. 19 Issue 5, p599 

    Intravenous immunoglobulin (IVIG) has a therapeutic potential in many autoimmune diseases. Based on its immune modulating and complement inhibiting effects, IVIG has been tested in systemic lupus erythematosus (SLE), but due to osmotic tubular injury caused by immunoglobulin-stabilizing sugar...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics